Sanofi SA - Ebitda

Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.

The item "Ebitda" stands at 12.23 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.

Sanofi SA's third quarter result of 4.21 Billion EUR for the item "Ebitda" represents an increase of 56.63 percent compared to it's second quarter result.

Also, Sanofi SA's third quarter result of 4.21 Billion EUR for the item "Ebitda" represents a decrease of -14.15 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 12.23 Billion EUR for the item "Ebitda" represents a decrease of -5.37 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 15.81 percent compared to the value the year prior.
The 1 year change in percent is 15.81.
The 3 year change in percent is -7.22.
The 5 year change in percent is 19.06.
The 10 year change in percent is 18.83.

The Serie's long term average value is 10.73 Billion Euros. It's latest available value, on 09/30/2025, is 13.99 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +35.37%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -12.76%.